Status:
COMPLETED
Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Complication of Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to assess whether early integration of palliative and supportive care services in care of patients hospitalized for hematopoietic stem cell transplantation (HSCT) can...
Detailed Description
This research study is evaluating the impact of early involvement of supportive care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients und...
Eligibility Criteria
Inclusion
- Patients Eligibility Criteria:
- Adult patients (≥18 years) with hematologic malignancy admitted to Massachusetts General Hospital for HSCT are eligible for the study.
- Ability to speak English or able to complete questionnaires with minimal assistance required from an interpreter or family member.
- Caregivers Eligibility Criteria:
- Adult caregivers (\>18 years) of patients undergoing HSCT at MGH who agreed to participate in study.
- A relative or a friend, identified by the patient who either lives with the patient or has in-person contact with him or her at least twice per week.
- Ability to read questions in English or willing to complete questionnaires with the assistance of an interpreter.
Exclusion
- Patients with prior history of HSCT.
- Patients undergoing HSCT for a benign hematologic condition (myelodysplastic syndrome (MDS) is not considered a benign hematologic condition and patients with MDS are eligible for the study)
- Significant uncontrolled psychiatric disorder (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the treating clinician believes prohibits informed consent or participation in the study.
- Patients enrolled on other supportive care intervention trials.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT02207322
Start Date
August 1 2014
End Date
August 1 2017
Last Update
October 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114